Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cytomx Thera (CTMX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 668,849
  • Shares Outstanding, K 45,010
  • Annual Sales, $ 71,620 K
  • Annual Income, $ -43,100 K
  • 36-Month Beta 1.43
  • Price/Sales 9.43
  • Price/Cash Flow N/A
  • Price/Book 4.14

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.51
  • Number of Estimates 8
  • High Estimate -0.38
  • Low Estimate -0.60
  • Prior Year 0.02
  • Growth Rate Est. (year over year) -2,650.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.51 +18.78%
on 11/20/18
15.37 -3.32%
on 12/12/18
+0.60 (+4.21%)
since 11/13/18
3-Month
12.51 +18.78%
on 11/20/18
19.79 -24.91%
on 09/14/18
-4.65 (-23.83%)
since 09/13/18
52-Week
12.51 +18.78%
on 11/20/18
35.00 -57.54%
on 03/08/18
-7.58 (-33.78%)
since 12/13/17

Most Recent Stories

More News
Downtrend Call Working As Cytomx Therapeut Stock Falls 37.1% (CTMX)

SmarTrend identified a Downtrend for Cytomx Therapeut (NASDAQ:CTMX) on August 15th, 2018 at $22.40. In approximately 4 months, Cytomx Therapeut has returned 37.08% as of today's recent price of $14.09....

CTMX : 14.86 (-1.00%)
Cytomx Therapeut Has Returned 38.4% Since SmarTrend Recommendation (CTMX)

SmarTrend identified a Downtrend for Cytomx Therapeut (NASDAQ:CTMX) on August 15th, 2018 at $22.40. In approximately 4 months, Cytomx Therapeut has returned 38.38% as of today's recent price of $13.80....

CTMX : 14.86 (-1.00%)
Consolidated Research: 2018 Summary Expectations for CarGurus, ARMOUR Residential REIT, Braskem S.A, HCI Group, Kimball Electronics, and CytomX Therapeutics -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CarGurus, Inc. (NASDAQ:CARG),...

ARR : 21.94 (+0.60%)
CTMX : 14.86 (-1.00%)
KE : 16.31 (-1.15%)
CARG : 35.68 (-0.97%)
BAK : 25.05 (-1.26%)
HCI : 52.02 (-3.04%)
Shares of CTMX Down 39.6% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Cytomx Therapeut (NASDAQ:CTMX) on August 15th, 2018 at $22.40. In approximately 3 months, Cytomx Therapeut has returned 39.58% as of today's recent price of $13.53....

CTMX : 14.86 (-1.00%)
Cytomx Therapeut Shares Down 33.0% Since SmarTrend's Sell Call (CTMX)

SmarTrend identified a Downtrend for Cytomx Therapeut (NASDAQ:CTMX) on August 15th, 2018 at $22.40. In approximately 3 months, Cytomx Therapeut has returned 33.02% as of today's recent price of $15.00....

CTMX : 14.86 (-1.00%)
CytomX Therapeutics Presents CX-072 Clinical Translational Data at 2018 SITC Annual Meeting

- Demonstrates Further Proof-of-Mechanism of Probody(TM) Platform -

CTMX : 14.86 (-1.00%)
Clinical Study Advancements for New Cancer Drug Candidates Boosting Optimism in Oncology Therapy Industry

Financialnewsmedia.com News Commentary

CTMX : 14.86 (-1.00%)
HZNP : 19.88 (+0.56%)
LLY : 114.86 (+0.45%)
ABBV : 87.71 (-1.00%)
MBRX : 1.26 (-14.86%)
CytomX to Present at the Jefferies 2018 London Healthcare Conference

CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on our Probody(TM) therapeutic...

CTMX : 14.86 (-1.00%)
CytomX Therapeutics (CTMX) Reports Q3 Loss, Lags Revenue Estimates

CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of -26.19% and -23.81%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?...

CTMX : 14.86 (-1.00%)
CytomX Therapeutics Announces Third Quarter 2018 Financial Results

ESMO Presentations Support CX-072 Product Profile and Probody(TM) Proof-of-Concept

CTMX : 14.86 (-1.00%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Falling.

See More Share

Trade CTMX with:

Business Summary

CytomX Therapeutics, Inc. is an oncology focused biopharmaceutical company. The Company is engaged in developing Probody(TM) therapeutics for the treatment of cancer. Its pipeline focuses areas consist of Precision cancer immunotherapy and Probody drug conjugates. CytomX Therapeutics, Inc. is headquartered...

See More

Key Turning Points

2nd Resistance Point 15.29
1st Resistance Point 15.08
Last Price 14.86
1st Support Level 14.66
2nd Support Level 14.45

See More

52-Week High 35.00
Fibonacci 61.8% 26.41
Fibonacci 50% 23.76
Fibonacci 38.2% 21.10
Last Price 14.86
52-Week Low 12.51

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar